ATTENDANCE FORM 8th NORTH WEST LIPID FORUM Wednesday 3 rd December 2014, 09: To reserve your place, please complete the form and return at your earliest convenience to or Fax to CORRESPONDENCE DETAILS Name: ……………………………………………………………………………………………………………………... GP Surgery/Hospital:.…….…………………………………………………………………………………………. Role/Position:…………………………………………………………………………………………………………… Address: ………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………….. Postcode: …………………………………………………………………………… Contact Number: …………………………………………………………………… Address: ………………………………………………………………………………………………………… Please state any dietary requirements: ……………………………………………………………………. Signature: ……………………………………………………………………………………………………………….. Date: …………………………………………………………………………………………………………………………

CPD accreditation 5 CPD applied for Invitation Organised by Dr Handrean Soran The organiser will not receive speaker honorarium or any other fee for chairing the sessions and organising the meeting This educational meeting has been supported by an unrestricted grant from Sanofi. Sanofi have had no input into the selection of speakers or topics for this meeting. 8 th NORTH WEST LIPID FORUM Wednesday 3 rd December th NORTH WEST LIPID FORUM Wednesday 3 rd December 2014 Venue: Radisson Blu Hotel, Manchester Airport, Chicago Avenue, Manchester Airport, Manchester M90 3RA, UK University of Manchester The Centre for Endocrinology & Diabetes

Registration and Tea Welcome Dr Handrean Soran Session 1Chair TBC NICE guidelines, their development and the international context. Professor Anthony S. Wierzbicki, Consultant in Metabolic Medicine & Chemical Pathology. Guy's & St Thomas' Hospitals, London, UK Why do we have British guidelines on hypertension, but not hyperlipidaemia? A disservice to people with hyperlipidaemia. Professor Paul Durrington, University of Manchester, Manchester, UK Coffee Session 2Chair Professor Paul Durrington An overview and what we learned from Simon Broome registry data? Professor Andrew Neil, Wolfson College, Oxford, UK Genetics of Familial Hypercholesterolaemia. Professor Steve Humphries, University College London, London, UK Familial Hypercholesterolaemia cascade testing in Wales; an experience so far. Dr Dev Datta Consultant in Biochemistry and Metabolic Medicine University Hospital Llandough, Wales, UK Panel Discussion Lunch and networking Session 3Chair Dr Mary Seed PCSK9: natural history and targeted treatment of GoF Mutations with PCSK9 Monoclonal Antibody and its effect in Homozygous Familial Hypercholestrolaemia. Dr Handrean Soran, Consultant Physician and Endocrinologist, Central Manchester University Hospital NHS Foundation Trust, Manchester, UK Liver transplantation as a therapeutic option in Homozygous Familial Hypercholestrolaemia: Overview of the Literature and a case presentation. Dr Anne-Marie Kelly, Consultant Chemical Pathologist & Hospital Dean, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK Homozygous Familial Hypercholestrolaemia and pregnancy. Sister Ruth Eatough, Cardiovascular Trials Unit, Central Manchester University Hospital NHS Foundation Trust, Manchester, UK A review of paradoxical HDL-C responses to fenofibrate, illustrated by a case report. Dr Jonathan Schofield, Clinical Research Fellow, University of Manchester, Manchester, UK Close and feedback Agenda